BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 25122627)

  • 1. Managing the ethical challenges of next-generation sequencing in genomic medicine.
    Clarke AJ
    Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing: considering the ethics.
    Davey S
    Int J Immunogenet; 2014 Dec; 41(6):457-62. PubMed ID: 25345691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ethical issues in genome-era].
    Kosugi S
    Nihon Rinsho; 2016 Jun; 74(6):1022-7. PubMed ID: 27311196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new genetics and informed consent: differentiating choice to preserve autonomy.
    Bunnik EM; de Jong A; Nijsingh N; de Wert GM
    Bioethics; 2013 Jul; 27(6):348-55. PubMed ID: 23718722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical and Policy Considerations for Genomic Testing in Pediatric Research: The Path Toward Disclosing Individual Research Results.
    Wong CS; Kogon AJ; Warady BA; Furth SL; Lantos JD; Wilfond BS
    Am J Kidney Dis; 2019 Jun; 73(6):837-845. PubMed ID: 30879919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Models of consent to return of incidental findings in genomic research.
    Appelbaum PS; Parens E; Waldman CR; Klitzman R; Fyer A; Martinez J; Price WN; Chung WK
    Hastings Cent Rep; 2014; 44(4):22-32. PubMed ID: 24919982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing--implications for clinical practice.
    Raffan E; Semple RK
    Br Med Bull; 2011; 99():53-71. PubMed ID: 21705347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethics.
    Fiore RN; Goodman KW
    Curr Opin Oncol; 2016 Jan; 28(1):83-7. PubMed ID: 26569425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation sequencing in psychiatric research: what study participants need to know about research findings.
    Mathieu G; Groisman IJ; Godard B
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2119-27. PubMed ID: 23725748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics.
    Rigter T; Henneman L; Kristoffersson U; Hall A; Yntema HG; Borry P; Tönnies H; Waisfisz Q; Elting MW; Dondorp WJ; Cornel MC
    Hum Mutat; 2013 Oct; 34(10):1322-8. PubMed ID: 23784691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical challenges of the use of whole exome sequencing in the clinic.
    Merrill SL; Vaidya A; Pyeritz RE
    World J Pediatr Congenit Heart Surg; 2013 Jan; 4(1):58-61. PubMed ID: 23799756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary findings from next generation sequencing: Psychological and ethical issues. Family and patient perspectives.
    Houdayer F; Putois O; Babonneau ML; Chaumet H; Joly L; Juif C; Michon CC; Staraci S; Cretin E; Delanoue S; Charron P; Chassagne A; Edery P; Gautier E; Lapointe AS; Thauvin-Robinet C; Sanlaville D; Gargiulo M; Faivre L
    Eur J Med Genet; 2019 Oct; 62(10):103711. PubMed ID: 31265899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical genetics and the genome].
    Gerdes AM; Vogel I
    Ugeskr Laeger; 2014 Nov; 176(46):. PubMed ID: 25394930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
    Ackerman SL; Koenig BA
    AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer gene sequencing: ethical challenges and promises.
    Devarakonda S; Govindan R; Hammerman PS
    Virtual Mentor; 2012 Nov; 14(11):868-72. PubMed ID: 23351899
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges.
    de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ
    Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.
    Middleton A; Morley KI; Bragin E; Firth HV; Hurles ME; Wright CF; Parker M;
    Eur J Hum Genet; 2016 Jan; 24(1):21-9. PubMed ID: 25920556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Have we asked too much of consent?
    Koenig BA
    Hastings Cent Rep; 2014; 44(4):33-4. PubMed ID: 25043364
    [No Abstract]   [Full Text] [Related]  

  • 20. Scanning the body, sequencing the genome: Dealing with unsolicited findings.
    Wouters RHP; Cornelis C; Newson AJ; Bunnik EM; Bredenoord AL
    Bioethics; 2017 Nov; 31(9):648-656. PubMed ID: 28975656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.